Literature DB >> 17028228

A yeast platform for the production of single-chain antibody-green fluorescent protein fusions.

Dagang Huang1, Eric V Shusta.   

Abstract

Fusion proteins comprised of a binding domain and green fluorescent protein (GFP) have the potential to act as one-step binding reagents. In this study, eight single-chain antibodies (scFv) and one single-chain T-cell receptor (scTCR) were secreted as fusions to GFP using a Saccharomyces cerevisiae expression system. Fusion protein secretion levels ranged over 3 orders of magnitude, from 4 microg/liter to 4 mg/liter, and correlated well with the secretion levels of the unfused scFv/scTCR. Three fusion types with various linker lengths and fusion orientations were tested for each scFv/scTCR. Although the fusion protein secretion levels were not significantly affected by the nature of the fusion construct, the properties of the fusion protein were clearly influenced. The fluorescence yield per fusion molecule was increased by separating the scFv/scTCR and GFP with an extended (GGGGS)3 linker, and fusions with scFv/scTCR at the carboxy-terminus were more resistant to degradation. By evaluating leader sequence processing and using GFP fluorescence to track intracellular processing, it was determined that the majority of fusion protein synthesized by the yeast was not secreted and in most cases was accumulating in an immature, although active, endoplasmic-reticulum (ER)-processed form. This contrasted with unfused scFv, which accumulated in both immature ER-processed and mature post-Golgi forms. The results indicated that yeast can be used as an effective host for the secretion of scFv/scTCR-GFP fusion proteins and that as a result of intracellular secretory bottlenecks, there is considerable yeast secretory capacity remaining to be exploited.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028228      PMCID: PMC1694270          DOI: 10.1128/AEM.01403-06

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  34 in total

1.  Fluobodies: green fluorescent single-chain Fv fusion proteins.

Authors:  R A Griep; C van Twisk; J M van der Wolf; A Schots
Journal:  J Immunol Methods       Date:  1999-11-19       Impact factor: 2.303

Review 2.  Selecting and screening recombinant antibody libraries.

Authors:  Hennie R Hoogenboom
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 3.  The uses of green fluorescent protein in yeasts.

Authors:  Amy L Hitchcock; Jason A Kahana; Pamela A Silver
Journal:  Methods Biochem Anal       Date:  2006

4.  Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy.

Authors:  G H Patterson; S M Knobel; W D Sharif; S R Kain; D W Piston
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

5.  The use of scFv-displaying yeast in mammalian cell surface selections.

Authors:  Xin Xiang Wang; Eric V Shusta
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

6.  De novo folding of GFP fusion proteins: high efficiency in eukaryotes but not in bacteria.

Authors:  Hung-Chun Chang; Christian M Kaiser; F Ulrich Hartl; José M Barral
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

7.  Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast.

Authors:  Yong-Sung Kim; Rashna Bhandari; Jennifer R Cochran; John Kuriyan; K Dane Wittrup
Journal:  Proteins       Date:  2006-03-01

8.  Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli.

Authors:  Keith D Miller; Jane Weaver-Feldhaus; Sean A Gray; Robert W Siegel; Michael J Feldhaus
Journal:  Protein Expr Purif       Date:  2005-08       Impact factor: 1.650

9.  Development of a novel strategy for engineering high-affinity proteins by yeast display.

Authors:  S A Richman; S J Healan; K S Weber; D L Donermeyer; M L Dossett; P D Greenberg; P M Allen; D M Kranz
Journal:  Protein Eng Des Sel       Date:  2006-03-20       Impact factor: 1.650

10.  Production of soluble and active transferrin receptor-targeting single-chain antibody using Saccharomyces cerevisiae.

Authors:  Benjamin J Hackel; Dagang Huang; Jennifer C Bubolz; Xin X Wang; Eric V Shusta
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

View more
  7 in total

1.  An enhanced approach for engineering thermally stable proteins using yeast display.

Authors:  Tej V Pavoor; Jean A Wheasler; Viraj Kamat; Eric V Shusta
Journal:  Protein Eng Des Sel       Date:  2012-07-05       Impact factor: 1.650

2.  A novel high-throughput screen reveals yeast genes that increase secretion of heterologous proteins.

Authors:  Alane E Wentz; Eric V Shusta
Journal:  Appl Environ Microbiol       Date:  2006-12-22       Impact factor: 4.792

3.  Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.

Authors:  Erik Kvam; Brent L Nannenga; Min S Wang; Zongjian Jia; Michael R Sierks; Anne Messer
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

4.  Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Authors:  Anatoliy Markiv; Richard Beatson; Joy Burchell; Ravi V Durvasula; Angray S Kang
Journal:  BMC Biotechnol       Date:  2011-11-30       Impact factor: 2.563

5.  An evolved Mxe GyrA intein for enhanced production of fusion proteins.

Authors:  Carrie J Marshall; Vanessa A Grosskopf; Taylor J Moehling; Benjamin J Tillotson; Gregory J Wiepz; Nicholas L Abbott; Ronald T Raines; Eric V Shusta
Journal:  ACS Chem Biol       Date:  2014-11-24       Impact factor: 5.100

6.  Expression of actively soluble antigen-binding fragment (Fab) antibody and GFP fused Fab in the cytoplasm of the engineered Escherichia coli.

Authors:  Supaluk Krittanai; Waraporn Putalun; Seiichi Sakamoto; Hiroyuki Tanaka; Thaweesak Juengwatanatrakul; Gorawit Yusakul
Journal:  Mol Biol Rep       Date:  2020-05-11       Impact factor: 2.316

7.  Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression.

Authors:  Frank Powilleit; Tanja Breinig; Manfred J Schmitt
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.